StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by valentinemassonon May 31, 2020 2:28pm

143 Views

Post# 31093875

RE:RE:RE:RE:RE:RE:ASCO

JHendrix wrote:
That's why we wait until Monday to determine effectiveness of ASCO.

IMO, as important as testing for cancer is, a solid NR related to C19 testing will be more impactful to SP than Aristole. Aristotle will have is day, later.

As a different poster mentioned, "Come for Covid. Stay for Aristotle". 2 stage covid testing very important and useful to Airlines, cruise lines, schools and workplaces. Alaska has began having anyone traveling there by Air needs to have passed a covid test previously to arriving. This is the new normal. Millions of tests will be needed over the course of the next 18-24 months. Surely SZLS will share the pie as will many others. Good luck to all. VM

Bullboard Posts

Anaergia expands relationship with PepsiCo